Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3995-4002

  Bredella, Miriam A ^a   Torriani, Martin ^a   Thomas, Bijoy J ^a   Ghomi, Reza Hosseini ^a   Brick, Danielle J ^a   Gerweck, Anu V ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPID STORAGE; MUSCLE; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 70349916249     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0438     Document Type: Article

References (39)

1. Christopher M, Hew FL, Oakley M, Rantzau C, Alford F 1998 Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 83:1668-1681 (Pubitemid 28501041)
2. Hoffman DM, Nguyen TV, O'Sullivan AJ, Baxter RC, Ho KK 1994 Diagnosis of growth hormone deficiency in adults. Lancet 344:482-483 (Pubitemid 24248279)
3. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738 (Pubitemid 32113289)
4. Yu AS, Keeffe EB 2002 Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2:11-19
5. Hwu CM, Kwok CF, Lai TY, Shih KC, Lee TS, Hsiao LC, Lee SH, Fang VS, Ho LT 1997 Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. J Clin Endocrinol Metab 82:3285-3292
6. Miller KK, Biller BM, Lipman JG, Bradwin G, Rifai N, Klibanski A 2005 Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 90:768-774 (Pubitemid 40279194)
7. Ho KK, O'Sullivan AJ, Hoffman DM 1996 Metabolic actions of growth hormone in man. Endocr J 43(Suppl):S57-S63 (Pubitemid 27014289)
8. Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N 2004 Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting. Eur J Endocrinol 150:779-787 (Pubitemid 38961650)
9. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC 2003 Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults. Eur J Endocrinol 149:511-519 (Pubitemid 38054694)
10. Bengtsson BA, Johannsson G 1998 The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future. Growth Horm IGF Res 8(Suppl B):27-35 (Pubitemid 29130115)
11. Franco C, Brandberg J, Lönn L, Andersson B, Bengtsson BA, Johannsson G 2005 Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12- month placebo-controlled trial. J Clin Endocrinol Metab 90:1466-1474 (Pubitemid 40464006)
12. Boesch C, Slotboom J, Hoppeler H, Kreis R 1997 In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37:484-493
13. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
14. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI, Caprio S 2002 Assessment of skeletal muscle triglyceride content by 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51:1022-1027 (Pubitemid 34438345)
15. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Häring HU 1999 Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119
16. 1HNMRspectroscopy study. Diabetologia 42:113-116
17. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
18. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ 2008 Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28:937-945
19. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M 2007 Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293:E1663-E1669 (Pubitemid 350255117)
20. Machann J, Stefan N, Schick F 2008 1HMRspectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 67:275-284
21. Petersen KF, Shulman GI 2002 Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90:11G-18G
22. Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A 2008 Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 295: E385-E392
23. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML 2002 Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067-2079 (Pubitemid 34521490)
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
25. Utz AL, Yamamoto A, Hemphill L, Miller KK 2008 Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab 93:2507-2514 (Pubitemid 352008514)
26. 1H-MRS. Magn Reson Imaging 25:1105-1111
27. Provencher SW 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
28. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S 2004 Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 80: 271-278 (Pubitemid 41079998)
29. Bredella MA, Utz AL, Torriani M, Thomas B, Schoenfeld DA, Miller KK 2009 Anthropometry, CT, and DXA as predictors ofGH deficiency in premenopausal women: ROC curve analysis. J Appl Physiol 106:418-422
30. Fowelin J, Attvall S, Lager I, Bengtsson BA 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443-1447
31. Johannsson G, Mårin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BA 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82:727-734 (Pubitemid 27106578)
32. Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P 2004 Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin EndocrinolMetab89:2192-2199 (Pubitemid 38619852)
33. Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO 2002 Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 87:2121-2127 (Pubitemid 34525079)
34. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6 (Pubitemid 20209464)
35. Franco C, Veldhuis JD, Iranmanesh A, Brandberg J, Lönn L, Andersson B, Bengtsson BA, Svensson J, Johannsson G 2006 Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausalwomenwith abdominal obesity. Eur J Endocrinol 155:261-268 (Pubitemid 44269442)
36. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Häring HU, Stumvoll M 2003 Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88: 1785-1791 (Pubitemid 36623405)
37. Vermathen P, Kreis R, Boesch C 2004 Distribution of intramyocellular lipids in human calf muscles as determined by MR spectroscopic imaging. Magn Reson Med 51:253-262 (Pubitemid 38168584)
38. Goto T, Onuma T, Takebe K, Kral JG 1995 The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841-845 (Pubitemid 26003018)
39. Johanson EH, Jansson PA, Lönn L, Matsuzawa Y, Funahashi T, Taskinen MR, Smith U, Axelsen M 2003 Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes. J Clin Endocrinol Metab 88:4232-4238 (Pubitemid 37153725)